✦ LIBER ✦

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma

✍ Scribed by van Klaveren, Rob J.; Aerts, Joachim G.J.V.; de Bruin, Hein; Giaccone, Guiseppe; Manegold, Christian; van Meerbeeck, Jan P.

Book ID: 118571209
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 354 KB
Volume: 43
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)00292-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inadequacy of the new Response Evaluatio

Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases

✍ Monetti, F; Casanova, S; Grasso, A; Cafferata, M.A; Ardizzoni, A; Neumaier, C.E 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Early sequential PET scanning and use of

Early sequential PET scanning and use of modified RECIST criteria in the evaluation of malignant pleural mesothelioma (MPM)

✍ O'Flaherty, J.; Knox, M.; Lucey, J.; Cuffe, S.; O'Byrne, K.J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Therapy response in malignant pleural me

Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT

✍ Christian Plathow; Michael Klopp; Christian Thieke; Felix Herth; Andreas Thomas; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 227 KB

Erratum to: Therapy response in malignan

Erratum to: Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT

✍ Christian Plathow; Michael Klopp; Christian Thieke; Felix Herth; Andreas Thomas; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 49 KB

Hyaluronic acid in the pleural fluid of

Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma

✍ Fujimoto, Nobukazu; Gemba, Kenichi; Asano, Michiko; Fuchimoto, Yasuko; Wada, Sae 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 396 KB

Comparison of tumor response by Response

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

✍ Julien Edeline; Eveline Boucher; Yan Rolland; Elodie Vauléon; Marc Pracht; Chris 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

## Abstract ## BACKGROUND: A significant improvement in overall survival (OS) was demonstrated in patients with advanced hepatocellular carcinoma (HCC) who received sorafenib (Sor) in the Sorafenib HCC Assessment Randomized Protocol (SHARP) study, in contrast to a response rate (RR) of 2% assessed